Recombinant Adenovirus-mediated VEGF_(121) cDNA Gene Transfer and Expression In vitro
Yue Wang
Abstract
Yue Wang
Abstract
The replication-incompetent adenoviral vector containing the cDNA of VEGF 121 was constructed. After transfection, individual viral plaques were isolated and amplified in HEK293 cells. Confirmed by PCR, both Adeno-X-VEGF 121 and Adeno-X-LacZ were propagated in HEK293 cells and were purified by CsCl density gradient centrifugation. Adenovirus-mediated VEGF 121 gene transfer promotes ECV304 proliferation and formation of capillary-like structures in vitro. The expression of VEGF 121 by adenovirus-infected ECV304 was quantified by enzymelinked immunosorbent assay. Peak VEGF 121 production was achived at 7~10 days after infection. The conditioned media from ECV304 infected with Adeno-X-VEGF 121 markedly enhanced vascular permeability. These data may support that adenovirus-mediated VEGF 121 cDNA gene transfer could provide a useful strategy for efficient delivery of VEGF 121 in the treatment of ischemic diseases.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The replication-incompetent adenoviral vector containing the cDNA of VEGF 121 was constructed. After transfection, individual viral plaques were isolated and amplified in HEK293 cells. Confirmed by PCR, both Adeno-X-VEGF 121 and Adeno-X-LacZ were propagated in HEK293 cells and were purified by CsCl density gradient centrifugation. Adenovirus-mediated VEGF 121 gene transfer promotes ECV304 proliferation and formation of capillary-like structures in vitro. The expression of VEGF 121 by adenovirus-infected ECV304 was quantified by enzymelinked immunosorbent assay. Peak VEGF 121 production was achived at 7~10 days after infection. The conditioned media from ECV304 infected with Adeno-X-VEGF 121 markedly enhanced vascular permeability. These data may support that adenovirus-mediated VEGF 121 cDNA gene transfer could provide a useful strategy for efficient delivery of VEGF 121 in the treatment of ischemic diseases.
Key concepts: Complementary DNA, Molecular biology, Transfection, In vitro, HEK 293 cells, Viral vector, Gene delivery, Genetic enhancement